Clinical Trials on Mirror Movements 2

Total 20889 results

Merck Sharp & Dohme LLC

Completed

A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED)

Type 2 Diabetes Mellitus
AstraZeneca

Completed

A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
AstraZeneca
Eli Lilly and Company

Completed

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

Type 2 Diabetes Mellitus

Korea, Republic of, Mexico, Germany, Greece, Argentina, India, Australia
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Type 2 Diabetes Mellitus

United States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
AstraZeneca
Eli Lilly and Company

Completed

Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione

Type 2 Diabetes Mellitus

United States
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

Type 2 Diabetes Mellitus

United States, Romania, Canada, Mexico, South Africa
AstraZeneca
Eli Lilly and Company

Completed

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Italy, Korea, Republic of, Hungary, Canada, Australia
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009)

Type 2 Diabetes Mellitus
AstraZeneca
Eli Lilly and Company

Completed

Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
AstraZeneca
Eli Lilly and Company

Completed

A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United Kingdom
National Institute of Diabetes and Digestive and...

Completed

The Effect of Ethanol on Overnight Glucose Regulation in Type 2

Type 2 Diabetes, Insulin Requiring

United States
Merck KGaA, Darmstadt, Germany

Completed

A Prospective, Observational Study to Assess and Evaluate the Use of Glucophage XR Therapy in the Management of Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Singapore
LG Life Sciences

Unknown

Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of
Prosidion Ltd.

Completed

A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM)

Type 2 Diabetes Mellitus

South Africa
Ankara University
Hacettepe University; The Scientific and Technological Research Council of...

Completed

The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Turkey
Tehran University of Medical Sciences

Completed

Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

Iran, Islamic Republic of
Mannkind Corporation

Completed

Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes

Type 2 Diabetes Mellitus
Bristol-Myers Squibb
Merck Sharp & Dohme LLC

Completed

Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
Abbott Nutrition

Completed

Comparison of Nutritional Products for People With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Genovate Biotechnology Co., Ltd.,

Completed

Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet

Type 2 Diabetes Mellitus

Taiwan
Edgar National Centre for Diabetes Research
University of Otago

Unknown

LOADD (Lifestyle Over and Above Drugs in Diabetes) Study

Type 2 Diabetes Mellitus

New Zealand
Texas A&M University
University of Michigan; Virginia Polytechnic Institute and State University

Completed

Balance Recovery Training for Fall Prevention in Retirement Communities

Accidental Falls, Aged, Exercise Movement Techniques
Universita di Verona

Not yet recruiting

Digital Telerehabilitation in Functional Motor Disorders

Functional Movement Disorder

Italy
HighTide Biopharma Pty Ltd

Recruiting

Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes

T2DM (Type 2 Diabetes Mellitus)

China
Chengdu Brilliant Pharmaceutical Co., Ltd.

Not yet recruiting

Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University

Recruiting

The Exploreration of the Management for the Positive IAA in Patients With Type 2 Diabetes After Premix Insulin Therapy

Type 2 Diabetes Mellitus

China
Xiangya Hospital of Central South University

Recruiting

Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy

Type 2 Diabetes Mellitus

China
University of Alabama at Birmingham

Completed

Return of First-phase Insulin Secretion in Type 2 Diabetes is Associated With Depletion of Pancreas Lipid

Type 2 Diabetes Mellitus

United States
Imperial College London
AstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...

Completed

Type 2 Diabetes Exemplar: A Remote Care Service for North West London (T2DEx)

Type 2 Diabetes Mellitus

United Kingdom
Universiti Sains Malaysia

Completed

An Intervention Study on the Effect of Brazilian Spinach Supplementation on Health Outcomes Among Type 2 Diabetes Patients in Hospital Universiti Sains Malaysia

Type 2 Diabetes Mellitus

Malaysia
PegBio Co., Ltd.

Completed

Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

Type 2 Diabetes Mellitus (T2DM)

China
University of Alabama at Birmingham
United States Department of Defense; Loma Linda University; Brenda Davis Nutrition... and other collaborators

Completed

Lifestyle Intervention to Treat Diabetes in the Marshall Islands

Type 2 Diabetes Mellitus
Centre Hospitalier Sud Francilien

Completed

Real-life Efficacy of Insulia® Tool in Patients Living With Type 2 Diabetes Treated With Basal Insulin Therapy as Part of a National Telemedicine Program (ETAPES) (INSULIA)

Type 2 Diabetes Mellitus

France
University of Oslo
Norwegian Diabetes Association

Completed

Women and Risk of Type 2 Diabetes

Type 2 Diabetes Mellitus

Norway
University Hospital, Caen

Completed

Switch From U-100 Insulin Analog to U-500 Regular Insulin in Pumps for Type 2 Diabetes

Type 2 Diabetes Mellitus
Riphah International University

Completed

The Effects of Pilates on Functional Capacity and Blood Glucose Levels in Adults With Diabetes Type 2

Type 2 Diabetes Mellitus

Pakistan
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)

Type 2 Diabetes Mellitus

India
Sanofi

Completed

Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy (SWITCH)

Type 2 Diabetes Mellitus

China
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period (LixiLan-G)

Type 2 Diabetes Mellitus

Estonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
Universidad de Guanajuato

Completed

Insulin Schemes for Type 2 Diabetes Control

Type 2 Diabetes Mellitus

Mexico
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone (SURPASS-1)

Type 2 Diabetes Mellitus

United States, Japan, India, Puerto Rico, Mexico
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)

Type 2 Diabetes Mellitus
Hospital de Clinicas de Porto Alegre

Completed

Improvement of Care for Outpatients With Type 2 Diabetes Through Self-Care Multidisciplinary Workshop for Diabetes

Type 2 Diabetes Mellitus

Brazil
Population Health Research Institute
Hamilton Health Sciences Corporation

Completed

Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)

Type 2 Diabetes Mellitus

Canada
University of Pretoria
South African Sugar Association

Completed

Nutrition Education Intervention for Adults With Type 2 Diabetes

Type 2 Diabetes Mellitus

South Africa
Catholic Kwandong University

Completed

Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation

Type 2 Diabetes Mellitus | Colonoscopy

Korea, Republic of
University of Alberta

Completed

Does Exercise Timing Affect Glucose Levels in People With Diabetes?

Type 2 Diabetes Mellitus

Canada
Novo Nordisk A/S

Completed

Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Diabetes | Type 2 Diabetes Mellitus

Taiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
Mitsubishi Tanabe Pharma Corporation

Completed

Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)

Type 2 Diabetes Mellitus

Japan
Samsung Medical Center
Novartis

Completed

The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of

3

Subscribe